Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07155564Recruiting

Validation of Energy Expenditure Measures Study

Role: collaborator

NCT07299604Not ApplicableCompleted

Effect of Chronic Exercise on Human Thermogenic Adipose Tissue & Elucidation of Mechanisms

Role: collaborator

NCT06382480Not ApplicableRecruiting

PROTeIn-rich Meals to Control Glucose

Role: collaborator

NCT01631123Not ApplicableCompleted

NUtriGenomic Analysis in Twins

Role: collaborator

All 4 trials loaded